IP Library › Granted Patent US 11,382,792
Granted Patent B2
US 11,382,792 · App. 16/569,236 · Granted Jul 12, 2022

Ophthalmic treatment device, method for controlling ophthalmic treatment device, and fundus lesion treatment method

Inventor: Jong Min Kim (Seoul, KR)
Assignee: Lutronic Vision Inc.
A61F9/008A61F2009/00863A61F2009/00897
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,382,792
App. No.
16/569,236
Granted
Jul 12, 2022
Kind
B2
Abstract

The present invention relates to an ophthalmic treatment device, a control method therefor and a fundus lesion treatment method, the ophthalmic treatment device comprising: a treatment beam generation unit for generating a treatment beam; a beam delivery unit for forming a path through which the treatment beam generated from the treatment beam generating unit is irradiated into a patient's fundus; and a control unit for controlling the beam delivery unit to irradiate the treatment beam into a location adjacent to the lesion area of the fundus.

Claims (21)

1. A treatment device, comprising:

a treatment beam generation unit generating a treatment beam;

a beam delivery unit delivering the treatment beam generated in the treatment beam generation unit to a patient's treatment area; and

a controller controlling at least one of the treatment beam generation unit and a beam delivery unit to radiate the treatment beam to one or more locations adjacent to a lesion area of the treatment area without radiating the treatment beam to the lesion area, the one or more locations being outside the lesion area and separated by 10-200 μm by a predetermined gap or more from a boundary of the lesion area so as to prevent the lesion area from expanding.

2. The treatment device of claim 1 , wherein the lesion area is any one of an area in which geography angiography has occurred, an area in which drugen is formed, an area in which blood leakage has occurred, and an area in which macular edema is formed.

3. The treatment device of claim 1 , wherein the treatment device is for treating ophthalmic disease and the treatment area is located in a patient's fundus.

4. The treatment device of claim 3 , wherein the controller controls to radiate the treatment beam along a pattern that partitions between the lesion area and a center of the fundus.

5. The treatment device of claim 3 , wherein the treatment beam transfers energy to a depth in which an RPE cell layer is located at the patient's fundus.

6. The treatment device of claim 3 , wherein the controller controls to radiate the treatment beam to the one or more locations that are separated by at least one RPE cell size from the boundary of the lesion area.

7. The treatment device of claim 1 , wherein a pattern of the treatment beam encloses the lesion area.

8. The treatment device of claim 7 , wherein the pattern of the treatment beam forms a closed curve that encloses the lesion area.

9. The treatment device of claim 1 , wherein the controller controls to radiate the treatment beam to form a first pattern and a second pattern, and the second pattern is separately located further than the first pattern from the boundary of the lesion area.

10. The treatment device of claim 9 , wherein a radiation gap of a treatment beam constituting the first pattern is smaller than that of a treatment beam constituting the second pattern.

11. The treatment device of claim 1 , wherein the treatment beam includes a plurality of beams, and the controller controls to sequentially radiate the plurality of beams at the same location and controls a parameter of the treatment beam.

12. The treatment device of claim 11 , wherein the parameter of the treatment beam is any one of an output, a beam size, and a pulse pattern of the treatment beam.

13. A method of treating a lesion, the method comprising:

determining a lesion area using an image of a treatment area comprising the lesion;

radiating a treatment beam to a plurality of locations adjacent to a boundary of the lesion area so as to prevent the lesion area from expanding, while not radiating the treatment beam to the lesion area,

wherein the radiating of the treatment beam comprises radiating the treatment beam at the plurality of locations being outside the lesion area and separated by 10-200 μm by a predetermined gap or more from the boundary of the lesion area.

14. The method of treating the lesion of claim 13 , wherein the lesion area is any one of an area in which geography angiography has occurred, an area in which drugen is formed, an area in which blood leakage has occurred, and an area in which macular edema is formed.

15. The method of treating the lesion of claim 13 , wherein the method of treating the lesion is for treating ophthalmic disease and the treatment area is located in a patient's fundus.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2025
From: LUTRONIC VISION INC.
To: R:GEN VISION, INC.
Reel/Frame 072481/0566 →
Continuity (3)
Continuation 15103213
Provisional Application 61913902 · Dec 9, 2013
Related Publication 20200069464A1 · Mar 5, 2020
Cited By (1)
US 12,396,887